Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

GV-150526A in development for stroke

April 5, 1996

TR-810 delivers SOD to the nervous system

April 5, 1996

Novel ETA/ETB antagonist reduces brain injury

April 5, 1996

PPI-368 selected for development

April 5, 1996

L-745870: D4 antagonist for schizophrenia

April 5, 1996

New antipsychotic drug in phase I at P&U

April 5, 1996

Pherin develops vomeropherins for anxiety

April 5, 1996

Coronary artery diagnostic to enter clinical studies

April 5, 1996

RSR13 enhances oxygen delivery to tissues

April 5, 1996

Pharmalytics develops anticocaine drugs

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...